Chang-xiao LIU, honorary president of Tianjin Institute of Pharmaceutical Research, professor of pharmacokinetics.
Prof. Chang-xiao LIU graduated from Beijing Medical School (also known as Medical Department of Peking University) in 1965. Shortly after graduation, he joined the Beijing Institute of Pharmaceutical Sciences. He worked as visiting scholar at Lunds Universitet (English: Lund University, Sweden) during 1986-1987 and was promoted to Professor at early of 1990s. Currently, Prof. Liu chairs the academic committee of Tianjn Institute of Pharmaceutical Research and is director of State Key Laboratory of Drug Delivery Technology and Pharmacokinetics. He is also the executive member of China Pharmacopeia Committee. Additionally, he has been appointed as guest professor of China Pharmaceutical University, Shenyang Pharmaceutical University, Tianjin University and other higher education institutes. He was nominated and elected as academician of Chinese Academy of Engineering in 2003. Prof. Liu chaired CSSX for over 10 years and retired as president in 2012.
Prof. Liu dedicated his life to pharmacology, particularly in pharmacokinetics field. He established the first specific laboratory for pharmacokinetics study in 1968. In 1975, pharmacokinetics was applied to review and assess new drug by Prof. Liu. The concept of pharmacokinetics was initially introduced to public and academia in China in 1980. In addition, He established the first state laboratory of pharmacokinetics in 1995 and deeply involved in GLP formulation process.
Overall, Prof. Liu has published over 350 peer-reviewed papers and 18 books. The paper titled “study of practical pharmacokinetics program” has been cited over 4700. Since 1986, Prof. Liu has hosted over 50 projects, received funding from national key basic research program, national science and technology foundation, as well as industry. He received “state allowance” in 1992, “model worker” and “the excellent scientist prize” in 2005 and 2011, respectively.
